Evaluating the prevalence and severity of NAFLD in primary care: the EPSONIP study protocol

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) affects 20–30% of the general adult population. NAFLD patients with type 2 diabetes mellitus (T2DM) are at an increased risk of advanced fibrosis, which puts them at risk of cardiovascular complications, hepatocellular carcinoma, or liver failure...

Descripción completa

Detalles Bibliográficos
Autores principales: Nasr, Patrik, Iredahl, Fredrik, Dahlström, Nils, Rådholm, Karin, Henriksson, Pontus, Cedersund, Gunnar, Dahlqvist Leinhard, Olof, Ebbers, Tino, Alfredsson, Joakim, Carlhäll, Carl-Johan, Lundberg, Peter, Kechagias, Stergios, Ekstedt, Mattias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056630/
https://www.ncbi.nlm.nih.gov/pubmed/33879084
http://dx.doi.org/10.1186/s12876-021-01763-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056630/
https://www.ncbi.nlm.nih.gov/pubmed/33879084
http://dx.doi.org/10.1186/s12876-021-01763-z

Ejemplares similares